McGlacken-Byrne SM, Conway GS. Premature ovarian insufficiency. Best Pract Res Clin Obstet Gynaecol. 2022;81:98–110.

Article  PubMed  Google Scholar 

Ishizuka B. Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI). Front Endocrinol (Lausanne). 2021;12:626924.

Article  PubMed  Google Scholar 

Szeliga A, Calik-Ksepka A, Maciejewska-Jeske M, Grymowicz M, Smolarczyk K, Kostrzak A, Smolarczyk R, Rudnicka E, Meczekalski B. Autoimmune diseases in patients with premature ovarian insufficiency-our current state of knowledge. Int J Mol Sci. 2021;22(5):2594.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsieh YT, Ho JYP. Thyroid autoimmunity is associated with higher risk of premature ovarian insufficiency-a nationwide Health Insurance Research Database study. Hum Reprod. 2021;36(6):1621–9.

Article  CAS  PubMed  Google Scholar 

La Marca A, Brozzetti A, Sighinolfi G, Marzotti S, Volpe A, Falorni A. Primary ovarian insufficiency: autoimmune causes. Curr Opin Obstet Gynecol. 2010;22(4):277–82.

Article  PubMed  Google Scholar 

Vogt EC, Breivik L, Royrvik EC, Grytaas M, Husebye ES, Oksnes M. Primary Ovarian Insufficiency in Women With Addison’s Disease. J Clin Endocrinol Metab. 2021;106(7):e2656–63.

Article  PubMed  PubMed Central  Google Scholar 

Codner E, Iniguez G, Hernandez IM, Lopez P, Rhumie HK, Villarroel C, Rey RA. Elevated anti-Mullerian hormone (AMH) and inhibin B levels in prepubertal girls with type 1 diabetes mellitus. Clin Endocrinol (Oxf). 2011;74(1):73–8.

Article  CAS  PubMed  Google Scholar 

Luo W, Mao P, Zhang L, Chen X, Yang Z. Assessment of ovarian reserve by serum anti-Mullerian hormone in patients with systemic lupus erythematosus: a meta-analysis. Ann Palliat Med. 2020;9(2):207–15.

Article  PubMed  Google Scholar 

Brouwer J, Dolhain R, Hazes JMW, Erler NS, Visser JA, Laven JSE. Decline of ovarian function in patients with rheumatoid arthritis: serum anti-Müllerian hormone levels in a longitudinal cohort. RMD Open. 2020;6(3):e001307.

Collins G, Patel B, Thakore S, Liu J. Primary Ovarian Insufficiency: Current Concepts. South Med J. 2017;110(3):147–53.

Article  PubMed  Google Scholar 

Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization. JAMA. 2017;318(19):1925–6.

Article  PubMed  Google Scholar 

Zhang H. Pros and cons of Mendelian randomization. Fertil Steril. 2023;119(6):913–6.

Article  PubMed  PubMed Central  Google Scholar 

Xiao Z, Wang Z, Zhang T, Liu Y, Si M. Bidirectional Mendelian randomization analysis of the genetic association between primary lung cancer and colorectal cancer. J Transl Med. 2023;21(1):722.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11(1):597.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: A review. Res Synth Methods. 2019;10(4):486–96.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Zhu Y, Wei J, Chen L, Chen S, Lai D. The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis. Climacteric. 2023;26(2):95–102.

Article  CAS  PubMed  Google Scholar 

Domniz N, Meirow D. Premature ovarian insufficiency and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol. 2019;60:42–55.

Article  PubMed  Google Scholar 

Jiao X, Zhang X, Li N, Zhang D, Zhao S, Dang Y, Zanvit P, Jin W, Chen ZJ, Chen W, et al. T(reg) deficiency-mediated T(H) 1 response causes human premature ovarian insufficiency through apoptosis and steroidogenesis dysfunction of granulosa cells. Clin Transl Med. 2021;11(6):e448.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao H, Gao L, Wang W. Advances in the cellular immunological pathogenesis and related treatment of primary ovarian insufficiency. Am J Reprod Immunol. 2022;88(5):e13622.

Article  CAS  PubMed  Google Scholar 

Lliberos C, Liew SH, Zareie P, La Gruta NL, Mansell A, Hutt K. Evaluation of inflammation and follicle depletion during ovarian ageing in mice. Sci Rep. 2021;11(1):278.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiong J, Tan R, Wang W, Wang H, Pu D, Wu J. Evaluation of CD4(+)CD25(+)FOXP3(+) regulatory T cells and FOXP3 mRNA in premature ovarian insufficiency. Climacteric. 2020;23(3):267–72.

Article  CAS  PubMed  Google Scholar 

David T, Ling SF, Barton A. Genetics of immune-mediated inflammatory diseases. Clin Exp Immunol. 2018;193(1):3–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medeiros MM, Silveira VA, Menezes AP, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Braz J Med Biol Res. 2001;34(12):1561–8.

Article  CAS  PubMed  Google Scholar 

Manger K, Wildt L, Kalden JR, Manger B. Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study. Autoimmun Rev. 2006;5(4):269–72.

Article  CAS  PubMed  Google Scholar 

Martins NFE, Seixas MI, Pereira JP, Costa MM, Fonseca JE. Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus. Clin Rheumatol. 2017;36(12):2853–4.

Article  PubMed  Google Scholar 

Mok CC, Chan PT, To CH. Anti-mullerian hormone and ovarian reserve in systemic lupus erythematosus. Arthritis Rheum. 2013;65(1):206–10.

Article  CAS  PubMed  Google Scholar 

Chen D, Yuan S, Zhan Z, Zhan Y, Yang X, Liang L. Assessment of ovarian reserve with anti-Mullerian hormone in female patients with systemic lupus erythematosus. Zhonghua Yi Xue Za Zhi. 2014;94(13):977–80.

CAS  PubMed  Google Scholar 

Lawrenz B, Henes J, Henes M, Neunhoeffer E, Schmalzing M, Fehm T, Kitter I. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus. 2011;20(11):1193–7.

Article  CAS  PubMed  Google Scholar 

Malheiro OB, Rezende CP, Rocha AL, Del Puerto HL, Ferreira GA, Reis FM. Regular menstrual cycles do not rule out ovarian damage in adult women with systemic lupus erythematosus. Gynecol Endocrinol. 2014;30(10):701–4.

Article  CAS  PubMed  Google Scholar 

Zhu Y, Wang B, Hao Y, Zhu R. Clinical features of myasthenia gravis with neurological and systemic autoimmune diseases. Front Immunol. 2023;14:1223322.

Article  CAS  PubMed  PubMed Central  Google Scholar